10/17/2018 Bispecific Single-Domain Antibody fused to Monoclonal Antibody (SMAB): The Natural Form

10/17/2018 Bispecific Single-Domain Antibody fused to Monoclonal Antibody (SMAB): The Natural Form

switchSENSE® Bispecific AntibodiesПодробнее

switchSENSE® Bispecific Antibodies

Webinar - Bispecific Antibodies: The Next Generation of Antibody TherapeuticsПодробнее

Webinar - Bispecific Antibodies: The Next Generation of Antibody Therapeutics

The success story of bispecific and trispecific antibodiesПодробнее

The success story of bispecific and trispecific antibodies

ASH 2018: Bispecific T-cell Engangers (BiTEs)Подробнее

ASH 2018: Bispecific T-cell Engangers (BiTEs)

Updates on the Development of Self‐Assembling Bispecific AntibodiesПодробнее

Updates on the Development of Self‐Assembling Bispecific Antibodies

Targeting BCMA with bispecific antibodies in R/R myelomaПодробнее

Targeting BCMA with bispecific antibodies in R/R myeloma

What are bispecific antibodies?Подробнее

What are bispecific antibodies?

Webinar - Bispecific Single-Domain Antibody fused to Monoclonal Antibody (SMAB): The Natural FormПодробнее

Webinar - Bispecific Single-Domain Antibody fused to Monoclonal Antibody (SMAB): The Natural Form

Bispecific Antibodies for Multiple MyelomaПодробнее

Bispecific Antibodies for Multiple Myeloma

Emerging treatments for myeloma: quadruplets, bispecific antibodies & CAR T-cellsПодробнее

Emerging treatments for myeloma: quadruplets, bispecific antibodies & CAR T-cells

What are bispecific antibodies?Подробнее

What are bispecific antibodies?

Advances in Antibody Discovery for Bispecific Therapeutics | Biology Solutions | Antibody ScreeningПодробнее

Advances in Antibody Discovery for Bispecific Therapeutics | Biology Solutions | Antibody Screening

Expression Platform for Producing Flexible and Novel Bispecific Modalities at Pandemic SpeedПодробнее

Expression Platform for Producing Flexible and Novel Bispecific Modalities at Pandemic Speed

Which is the Most Important Target for Monoclonal Antibodies in Myeloma Therapy?Подробнее

Which is the Most Important Target for Monoclonal Antibodies in Myeloma Therapy?

Bispecific antibodies for R/R AML: ongoing clinical trialsПодробнее

Bispecific antibodies for R/R AML: ongoing clinical trials

T-cell bispecific antibody targeting intracellular WT1 in AMLПодробнее

T-cell bispecific antibody targeting intracellular WT1 in AML

Drawn to Science | T-cell bispecific antibodiesПодробнее

Drawn to Science | T-cell bispecific antibodies

Bispecific antibodies in lung cancerПодробнее

Bispecific antibodies in lung cancer